DISCOVERY RESEARCH

The greatest challenge in medicine lies in expanding our understanding of diseases and their treatment. Which is why, Research & Development is the future of every pharmaceutical enterprise.

At Wallace, we are committed to providing accelerated, advanced solutions for our customers. Our R&D department has developed advanced formulations to add to our portfolio of providing solutions for various therapeutic categories.

LYNX GEL – A Research Product of Wallace Pharmaceuticals.

This original and innovative formulation was developed for treatment against P.acne, the bacteria causing acne vulgaris. This formulation was developed using Lincomycin, a highly effective agent against P. acne.
In clinical multicentric trials, Lynx gel fared excellently with efficacy around 74% and a good safety profile. Lynx Gel is now one of the well-accepted products for acne vulgaris (Grade - II and Grade - III) in the market.